Biosion Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 95

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 16

Biosion General Information

Description

Developer of biomedical drugs designed to treat immune and oncology diseases. The company utilizes proprietary antibody discovery platforms, a clinical-stage biologics pipeline, high-throughput endocytosis technology, bispecific antibody engineering, and global research operations, providing monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, clinical drug assets, preclinical drug assets, and injectable medications for pharmaceutical companies to enable patients to benefit from the treatment of immune and oncology diseases.

Contact Information

Website
www.biosion.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building D, Zhongdan Garden, Longshan South Road
  • Jiangbei New Area
  • Nanjing, Jiangsu 210061
  • China
+86 025
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 5th Floor, Building D, Zhongdan Garden, Longshan South Road
  • Jiangbei New Area
  • Nanjing, Jiangsu 210061
  • China
+86 025

Biosion Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private 22-Jan-2026 Completed Generating Revenue
11. Secondary Transaction - Private 04-Aug-2025 Completed Generating Revenue
10. Later Stage VC 04-Aug-2025 Completed Generating Revenue
9. Later Stage VC (Series B1) 23-Apr-2023 Completed Generating Revenue
8. Later Stage VC 03-Jan-2023 Completed Generating Revenue
7. Later Stage VC (Series B) 28-Dec-2022 Completed Generating Revenue
6. Later Stage VC 29-Jul-2022 Completed Generating Revenue
5. Later Stage VC 12-Jul-2022 Completed Generating Revenue
4. Early Stage VC (Series B) 09-Dec-2021 $45.8M Completed Generating Revenue
3. Secondary Transaction - Private 17-Sep-2021 $34.8M Completed Generating Revenue
To view Biosion’s complete valuation and funding history, request access »

Biosion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biomedical drugs designed to treat immune and oncology diseases. The company utilizes proprietary antibody
Drug Discovery
Nanjing, China
95 As of 2025

Valby, Denmark
 

Woburn, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosion Competitors (2)

One of Biosion’s 2 competitors is Genmab, a Formerly VC-backed company based in Valby, Denmark.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genmab Formerly VC-backed Valby, Denmark
Harbor-med Corporation Woburn, MA
You’re viewing 2 of 2 competitors. Get the full list »

Biosion Patents

  • 121

    Total Documents Applications and Grants

  • Total Patents Families

  • 41

    Granted

  • 56

    Pending

  • Expiring in next 12 mo

Biosion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026219135-A1 Antibodies binding pd-l1 and uses thereof Pending 15-Apr-2025
WO-2026179935-A1 Antibodies binding tslpr and uses thereof Pending 28-Feb-2025
WO-2026158563-A1 Antibodies binding cdh6 and uses thereof Pending 24-Jan-2025
WO-2026149472-A1 Antibodies against folr1 and uses thereof Pending 08-Jan-2025
WO-2026149474-A1 Antibodies binding folr1 and uses thereof Pending 08-Jan-2025 A61P35/00
To view Biosion’s complete patent history, request access »

Biosion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosion Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guangzhou Fund Government Minority
Huangpu Biomedical Industry Investment Fund Growth/Expansion Minority
Shenzhen Dongfang Huisheng Capital Management Corporation Minority
Hangzhou Gupu Asset Management Company Asset Manager Minority
Harmony Invest Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Biosion FAQs

  • When was Biosion founded?

    Biosion was founded in 2017.

  • Where is Biosion headquartered?

    Biosion is headquartered in Nanjing, China.

  • What is the size of Biosion?

    Biosion has 95 total employees.

  • What industry is Biosion in?

    Biosion’s primary industry is Drug Discovery.

  • Is Biosion a private or public company?

    Biosion is a Private company.

  • What is Biosion’s current revenue?

    The current revenue for Biosion is .

  • How much funding has Biosion raised over time?

    Biosion has raised $133M.

  • Who are Biosion’s investors?

    Guangzhou Fund, Huangpu Biomedical Industry Investment Fund, Shenzhen Dongfang Huisheng Capital Management, Hangzhou Gupu Asset Management Company, and Harmony Invest are 5 of 16 investors who have invested in Biosion.

  • Who are Biosion’s competitors?

    Genmab and Harbor-med are competitors of Biosion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process